Revenue fell by 18.9 percent to NOK 3.0 million (3.7).
"Although we are facing some short-term challenges, the certified high quality of our products and increased market dynamics, combined with an expanded and well-received product range, make us confident that we will gradually increase our revenues over the coming quarters," commented CEO Ulf Ritsvall.
Gross profit reached NOK 1.5 million (-3.0), with a gross margin of 50.0 percent.
EBITDA was NOK -18.0 million (-19.1).
Operating result was NOK -19.2 million (-20.2).
Both pre-tax and after-tax results amounted to NOK -18.9 million (-20.1).
Earnings per share totaled NOK -0.16 (-0.19).
Net cash flow from operating activities amounted to NOK -13.5 million (-13.5).
Cash and cash equivalents stood at NOK 7.4 million (45.5).
| Next Biometrics, MNOK | Q3-2025 | Q3-2024 | Change |
| Net revenue | 3.0 | 3.7 | -18.9% |
| Gross profit | 1.5 | -3.0 | |
| Gross margin | 50.0% | ||
| EBITDA | -18.0 | -19.1 | |
| Operating result | -19.2 | -20.2 | |
| Result before tax | -18.9 | -20.1 | |
| Net result | -18.9 | -20.1 | |
| Earnings per share, NOK | -0.16 | -0.19 | |
| Net cash flow from operating activities | -13.5 | -13.5 | |
| Cash and cash equivalents | 7.4 | 45.5 | -83.7% |
